Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor-associated glycoprotein 72 (TAG-72) is a high molecular weight, mucin-like glycoprotein complex found predominantly on the surface of many cancer cells. It is minimally expressed in normal adult tissues, with the exception of secretory endometrium. TAG-72 serves as a tumor marker (CA 72-4) and a potential therapeutic target. High expression correlates with aggressive clinicopathologic features and poorer prognosis. Therapeutic strategies include monoclonal antibodies and CAR-T cell therapies.
Monoclonal antibody targeting TAG-72 for targeted therapy and imaging; CAR-T cell therapy targeting TAG-72 for immune-mediated tumor cell destruction
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor-associated Glycoprotein 72 (TAG-72).